ascendis pharma glp-1 receptor agonist weight management diabetes treatments Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies GLP-1 receptor agonists in the
Description
doi: 10.2337/diab.45.6.832 144 HunterKHlscherC
J Obes Metab Syndr 2021;30:3205.ArticlePubMedPMC 99
Diabetol Metab Syndr 17 , 179 (2025)
While they share a common mechanismmimicking the GLP-1 hormone to stimulate insulin secretion, suppress glucagon release, and slow gastric emptyingthey differ in their molecular structures, dosing schedules, efficacy, and side effect profiles
10.1038/aps.2011.168 49 HansotiaT.MaidaA.FlockG.YamadaY.TsukiyamaK.SeinoY.et al
